Researchers at UC are enrolling patients in a clinical trial looking attargeted gene therapies in patients with early stage lung cancer who have hadsurgery.
Researchers at the University of Cincinnati (UC) College of Medicine havediscovered a new potential strategy to personalize therapy for brain and bloodcancers.
The UC Cancer Institute's Clinical Trials Office has been selected to receivefinancial support from the NCI's National Clinical Trials Network for beinghigh performing.
Thanks to funding support from GIVEHOPE and BSI Engineering, Inc., scientistsat UC can continue research that could help better treat pancreatic cancerpatients.
Jianjun Chen, PhD, received a $550,000 Leukemia and Lymphoma Society ScholarAward to support research looking at the role of TET1 protein in acute myeloidleukemia.
The UC Cancer Institute is hosting a free educational event surroundingpancreatic cancer for patients, survivors, their families and the community.
To say Ft. Mitchell, Kentucky resident Doug Lange, 63, is always on the go isan understatement.
Troy Witt, 65, a London, Kentucky resident, completed treatment at theCincinnati Children's/UC Health Proton Therapy Center in Fall 2016. Now, he'sback to enjoying life.